Nairobi, Feb. 8 -- Med Aditus Pharmaceuticals, an American-based drugs manufacturer, is set to construct a Sh1.6 billion plant at the Great Lakes University of Kisumu (GLUK) in Kibos.

In a concession agreement signed by Kisumu County, GLUK and Med Aditus, the US firm undertook to produce high-quality subsidised drugs.

Kisumu Governor Prof Anyang' Nyong'o, who signed the deal on behalf of the county government, said the project would create employment opportunities and boost medical supplies in the region and countrywide.

"The investment will be producing two billion tablets per year at a highly subsidised cost," said Governor Nyong'o.

"By producing medicines locally, Med Aditus will reduce our dependence on imports, improve our supply...